- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06054737
Chronic Venous Insufficiency and Balneotherapy
Effectiveness of the Spa Therapy Program of Royat in Chronic Venous Insufficiency
The aim of this clinical trial is to assess the efficacy of the balneotherapy program (therapeutic orientation: Phlebology) in terms of chronic venous disease improvement and related quality of life, in patients presented with advanced chronic venous insufficiency (i.e., with C4-C5 of severity classification).
The multicenter randomized controlled trial (RCT) "Thermes & Veines" that aimed at evaluating balneotherapy in patients with advanced chronic venous insufficiency is considered as the reference study. The French National Academy of Medicine encourages the re-use of data of published RCT when available. In this context, the current study is designed as a single-arm prospective study with indirect comparison using propension score. The Control group consists of the 197 patients which were allocated to the Control group of the "Thermes & Veines".
All patients enrolled in the current study benefit of 18-days of spa treatment with Mineral Water of Royat, and examination with vascular practitioner at enrollment and 6 months after the beginning of spa treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Auvergne
-
Royat, Auvergne, France, 63130
- Thermes de Royat
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Primary or post-thrombotic CVD with confirmed diagnosis by by duplex ultrasound examination (last available exam);
- With CVI classified as C4a, C4b, or C5)
- Available for balneotherapy program within the 2 next months
- With health insurance affiliation.
Exclusion Criteria:
- Active venous thrombosis, recent or ongoing erysipelas, peripheral arterial pathology (ankle brachial index < 0.70).
- Walking difficulty
- Neurologic diseases of the lower limbs
- Presenting or likely to present a contraindication to thermal treatments, with planned surgery;
- Having already benefited from a thermal treatment whatever the indication during the last 6 months
- Chronic infectious disease, cancer, heart, kidney or liver failure;
- Pregnant, breastfeeding women or women planning a pregnancy within the year;
- Persons deprived of their liberty or subject to psychiatric care or subject to a measure of legal protection or unable to express their consent;
- Patient likely to not respect the protocol or not to be able to attend the visits, particularly given the study follow-up;
- Living at more than 30 minutes from the thermal site or who cannot be accommodated less than 30 minutes from the thermal site;
- Already included in a clinical trial or in the exclusion period of a clinical trial.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
SPA THERAPY PROGRAM
3-week spa therapy program with Mineral Water of Royat in addition to standard of care for chronic venous insufficiency
|
Balneotherapy program Four balneotherapy sessions per day, 6 days a week during 3 weeks The balneotherapy sessions included:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from baseline in CIVIQ-2 score at 6 months
Time Frame: Baseline (D1) and final (6 months)
|
The Chronic Venous Insufficiency Quality of Life Questionnaire (CIVIQ) is a disease-specific instrument to measure the impact of chronic venous insufficiency on patients' lives.
CIVIQ-2 or CIVIQ-20 is a self-administered questionnaire that consists in 20 questions of the CIVIQ result in a global score.
All questions have a 5-point response category, with higher scores reflecting more severe impairment.
The CIVIQ-20 score ranges from 20 (minimal impact) to 100 (maximal impact).
|
Baseline (D1) and final (6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from baseline in Quality of Life at 6 months
Time Frame: Baseline (D1) and final (6 months)
|
Quality of life is measured using the generic EUROQOL (EQ-5D-3L) questionnaire.
The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 3 levels: no problems, some problems, and extreme problems.
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions.
This decision results into a 1-digit number that expresses the level selected for that dimension.
The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state).
|
Baseline (D1) and final (6 months)
|
Changes from baseline in 0-100 VAS leg pain related to chronic venous insufficiency at 6 months
Time Frame: Baseline (D1) and final (6 months)
|
Pain intensity is measured using a 0 (no pain)-100 (Worse pain) Visual Analogic Scale (VAS).
|
Baseline (D1) and final (6 months)
|
Frequency of adverse events throughout the study
Time Frame: From inclusion to the final visit at 6 months]
|
Adverse events are described using MedDRA and each event frequency is calculated.
|
From inclusion to the final visit at 6 months]
|
Participants' satisfaction with the spa therapy program at the end of the program and at 6 months
Time Frame: 20 days and 6 months
|
Opinion of the patient is measured using a 5-point Likert scale ranging from 1 ("not at all satisfied") to 5 ("very satisfied")
|
20 days and 6 months
|
Medical-economic impact of the spa therapy program at 6 months
Time Frame: 6 months
|
EQ-5D-3L score at 6 months and frequency of adverse events related to chronic venous insufficiency. scores ranges from -0.541 (higher impact of health on quality of life) to 0.982 (lower impact of health on quality of life) |
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Geoffroy COUCHET, PD, Private Practitioner
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C1688
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venous Insufficiency (Chronic)(Peripheral)
-
State Budgetary Healthcare Institution, National...CompletedEndothelial Dysfunction | Venous Insufficiency of Leg | Venous Insufficiency (Chronic)(Peripheral)Russian Federation
-
Imperial College LondonUniversity of Edinburgh; British Heart FoundationRecruitingPost Thrombotic Syndrome | Chronic Venous Insufficiency | Iliac Vein Obstruction | Chronic Venous Thrombosis | Iliac Vein StenosisUnited Kingdom
-
Value Outcomes Ltd.Alfasigma S.p.A.RecruitingChronic Venous Disease | Chronic Insufficiency VenousCzechia
-
Ten Sun Pharma Company LimitedCompletedChronic Venous Insufficiency | Varicose Vein | Superficial Vein ThrombophlebitisTaiwan
-
University of ZurichJH Rahn Foundation, ZurichCompletedChronic Venous Insufficiency | Post-thrombotic SyndromeSwitzerland
-
Angiodynamics, Inc.Completed
-
Shannon HernonGalway ClinicUnknownChronic Venous InsufficiencyIreland
-
Virginia Commonwealth UniversityCompletedChronic Venous InsufficiencyUnited States
-
University of ZurichUnknown
-
TheraclionRecruitingChronic Venous InsufficiencyUnited States, Austria, Czechia
Clinical Trials on SPA THERAPY
-
Le Syndicat Intercommunal pour le Thermalisme et...University Grenoble Alps; FloralisRecruitingChronic Venous InsufficiencyFrance
-
University Hospital, Clermont-FerrandCompleted
-
Association Francaise pour la Recherche ThermaleUnknown
-
Centre Hospitalier Universitaire de NīmesTerminatedPulmonary Disease, Chronic ObstructiveFrance
-
University of BordeauxRecruitingKnee OsteoarthritisFrance
-
Association Francaise pour la Recherche ThermaleCompleted
-
University of RzeszowCompletedQuality of Life | Osteoarthritis | Elderly | Balneology
-
Abant Izzet Baysal UniversityCompleted
-
Association Francaise pour la Recherche ThermaleUniversity Hospital, Clermont-FerrandCompletedMusculoskeletal DisordersFrance
-
Azienda Ospedaliera Universitaria SeneseCompleted